l

The content of this website is intended for healthcare professionals only

Call made for ‘national strategy for neurology’

House of Lords debates neurological care

Jo Carlowe

Monday, 12 December 2011

Members of the House of Lords have called for the introduction of ‘a national strategy for neurology’.

In a recent debate in the House, Members, including the vice-president of the Muscular Dystrophy Campaign, debated the support currently available for people with neurological conditions.

Lord Dubs (Labour), tabled and opened the debate calling for the national strategy.

Baroness Thomas of Winchester (Liberal Democrat), vice-president of the Muscular Dystrophy Campaign spoke of support for conditions with care advisors and nurses:

“Neuromuscular conditions are progressive, so it is essential for patients to receive ongoing input from a co-ordinated multidisciplinary team of specialist health professionals to manage changing symptoms, to reduce complications and to provide expert advice on equipment and treatments.”

Baroness Hollins (Crossbench), former President of the Royal College of Psychiatrists, drew on her experience as a doctor working with disabled people for 30 years and spoke of attending to the needs of patients with spinal cord injuries.  

While Lord Macdonald of Tradeston (Labour), a patron of the Dystonia Society. raised awareness of the condition.

“Dystonia is unusual in that it is not degenerative, but it is also not curable, so people with dystonia often have to live with its disabling symptoms for 40 to 50 years or more. It is therefore essential that they receive treatment that effectively mitigates their symptoms. This can make the difference between a lifetime of disability, relying on others for care and benefits, or a life of economic independence, actively contributing to society.”

Responding on behalf of the government Earl Howe (Conservative) agreed that revision was required.

“Change is needed, and through the health reforms currently progressing through this House we want to ensure that we have health outcomes that are among the very best in the world,” he said.

Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470